Helen S. Kim

Director

Ms. Kim currently serves as a senior managing director at Vida Ventures, LLC, a position which she has held since April 2019. She also currently serves on the Board of Directors for A2 Biotherapeutics, Inc., ReCode Therapeutics, Inc., IconOVir Bio, Inc., Aktis Oncology, PACT Pharma, Protego Therapeutics, and InduPro Labs. Prior to her current role, Ms. Kim was a Partner at the Column Group from 2018-2019 and the Executive Vice President, Business Development at Kite Pharma, Inc. from 2014-2018. Ms. Kim also held senior positions at NGM Biopharmaceuticals, Inc as Chief Business Officer (2009-2012) and Strategic Advisor (2012-2014). She also served as the Chief Executive Officer and President of Kosan Biosciences from 2007-2008. Ms. Kim’s additional industry experience includes executive and leadership positions at Affymax, Inc., Onyx Pharmaceuticals, Inc., Protein Design Labs, Inc., and Chiron Corporation.  Ms. Kim received a BS in Chemical Engineering from Northwestern University and an MBA from the University of Chicago.